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Non-voluntary euthanization of dementia patients, the majority of whom are
severely conscious-state transition-impaired because of both high levels of anti-
somnogenic cytokine levels and circadian disruption, indicates the lack of measure-
ment of decision-making decline and conscious-state transition in palliative care
settings. This chapter explains why and how to setup medically-meaningful tests to
collect these measurements based on environmental-interactive parameters of
nonconscious testing in circadian calibrated XR or virtual reality platforms. It also
mentions worthy opportunities in relationship to the Human Connectome Project,
including the Alzheimer’s Disease Connectome Project.
Keywords: dementia, euthanization, virtual reality, XR, human connectome
project, Alzheimer’s Disease, conscious-state transition, decision-making
incompetence
1. Introduction
Dementia is a prominent symptom of various diseases and not just a disease in
and of itself. It is part of brain disease transition such as following virus-infected
inflammation through increased neurodegeneration and brain network
dysfunctioning.
It renders difficulty in recognition and response to daily environmental infor-
mation which are needed in short-term learning and recall and decision-making
[1, 2]. In general, one of the most disturbing characteristics of neuroinflammatory
diseases is loss of conscious-state transition [3]. This is a type of disability or
impairment that results in the presence of persistently high levels of anti-
somnogenic cytokines [4, 5], and common to Alzheimer’s Disease patients [6]. It is
alsoo associated with disruption of circadian synchronization between neuronal
networks of the brain [7, 8].
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A dementia patient’s care-giving team is presumed to include certified doctors
and nurses qualified in early diagnosis and strategies for dementia-symptom man-
agement. The targets of such caregiving include optimizing physical health, cogni-
tion, activity and well-being identifying and treating accompanying physical illness
detecting and treating challenging behavioral and psychological symptoms provid-
ing information and long-term support to carers (WHO).
Section 4.1 of the Dutch euthanization law [9] declares that euthanasia may be
given to a patient who is no longer mentally competent as a result of advanced
dementia, and that the doctor does not need to agree with the patient regarding the
time or manner of euthanatic execution based on a physician declaration of patient
inability to comprehend the subject.
Euthanization is delivered via anesthetics without acknowledging the surge of
neurophysiological coherence and connectivity in the forced-dying brain [10] or on
the basis of any measured disability of a patient to change from one conscious-state
to any other. The degree that sensory information processing and conscious mem-
ory, awareness, learning and recall are supposed to be fully disabled [11] by the
simple observation of delirium seems to possibly have led to an unchecked medical
assumption that an overdosage of anesthetic-euthanatic neurotoxins is sufficient to
overcome the disability and trigger instant brain death. However, the research
shows that this is invalid and that memory formation- and indeed, brain survival
mechanisms - are evolved to be much smarter, enabling survival-related learning
related neuronal synaptic plasticity changes to occur even under deep anesthesia
[12, 13].
In 2019, 146 dementia patients were euthanized in the Netherlands, 14% less
frequently than the previous year [14].
The English version Regional Euthanization Review Committees- The
Netherlands, report (2018) [9] states that.
Dementia
Two notifications in 2018 involved patients in an advanced or very advanced stage of
dementia who were no longer able to communicate regarding their request and in
whose cases the advance directive was decisive in establishing whether the request was
voluntary and well considered. See case 2018-41, described in Chapter II, and case
2018-21, published on www.euthanasiecommissie.nl.
In 144 cases the patient’s suffering was caused by early-stage dementia. These
patients still had insight into their condition and its symptoms, such as loss of
bearings and personality changes. They were deemed decisionally competent with
regard to their request because they could still grasp its implications. Case 2018-123,
described in Chapter II, is an example.
But, the section titled Advanced Directive Points to Consider (Section 4.1, f, (see
Annual Reports, Dutch Euthanasia Committee [15]) requires physicians to answer:
Are there any contraindications that are inconsistent with the advance directive and
preclude the performance of euthanasia?
If so, this statement represents one opportunity to provide an argument that all
dementia patients deserve medically-meaningful conscious-state transition moni-
toring and decision-competence evidence before non-voluntary euthanization can
be legally authorized.
Such monitoring technology would enable demonstration of key factors of non-
eligibility when a patient is unable to transition into unconsciousness or brain death
instantaneously or for up to 36 hours - even following severe anesthesia and cardiac
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arrest [16] simply because of the nature of the disease’s impact on the brain (see
Figure 1 below).
The euthanization method which is intended as a pain-free killing is error-prone
with patient re-awakening rather than instant dying [17, 18] on record. Anesthetic
drugs targeted to ion channels affect neuronal activity in the Central Nervous
System (including the brain), the peripheral nervous system (PNS) and all
connected organs, and the cardiovascular system [19]. Barbiturates such as
pentobarbital suppress the central nervous system (CNS) by binding to gamma-
aminobutyric acid (GABA) A subtype receptors, alters inhibitory postsynaptic
CL- currents while simultaneously inhibiting excitatory presynaptic nerve terminal
signal event transmission. This is supposed to sustain the opening of chloride chan-
nels and results in the suppressed neuronal activation of oscillations throughout the
brain and sensory management throughout the entire system [20–23]. The
GABAergic thalamic neurons would also therefore inhibit retinally-driven activity,
and likewise disable input to the geniculo-hypothalamic pathway which is activated
by crossed retinal inputs leading to the suprachiasmatic nucleus (SCN). In this way,
brainwave activities related to conscious-state transition and measured by
Bispectral Index (BIS) monitors [24] or Guedel’s classification system [25] are
logistically absent, thereby theoretically preventing patient awakening and patient
awareness or memory.
However, the research shows that brain death and cardiac death are not simul-
taneously correlated [26–29]). In research review by Robijn (2020) as part of an
academic thesis submission, Robijn reports correlation between BIS and the
Richmond Agitation-Sedation Scale (RASS) (p < 0.0004) including reporting
patients ‘awake’ during euthanization despite observational physician [30] deci-
sions that the patients were dead [31, 32]. Also, memory formation also continues
under anaesthesia [12, 33, 34]. On closer inspection of the events, one finds that the
high dosage anesthetics such as 9 mg/L pentobarbital intravenous injection used in
euthanization in the Netherlands has explicit pharmacological warnings that the
neurotoxic compound cannot reach the brain in one minute intravenous application
and that that the accelerated injection causes gangrene, body-wide joint pain and
tissue irritation for any intravenous-administered dosages above 0.5 mg/l. Further-
more, it reduces IL-1beta cytokine release by only 30–40%, while endogenous
tumor necrosis factor (TNF-α) transport becomes elevated in a process that remains
Figure 1.
A list of features in the progression of amnesiac-related brain inflammation from disease or neurological
disorders leading to risks that may compromise euthanization patient safety.
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persistent on behalf of neurotoxin breakdown and elimination that can last for as
many hours as the 36-hour half life of the anesthetic itself [30]. This process is part
of inherent mechanisms of survival, regardless the neurotoxic, and it is automati-
cally geared to protect the brain with interleukin-1β (IL-1β), and interleukin-6
(IL-6) pleiotropic mechanisms [6, 35–37].
This is significant considering the fact that, in the Netherlands alone, more than
32,000 killed patients have reportedly also died in conditions of unconsciousness
with profound dehydration; and where, at least one pro-euthanization physician
promoted the killing of a schizophrenic mentally ill patient to a general public
readership with significant reference to the patient’s ethnicity and immigrant
socioeconomic demeaning reference to drug-addiction [38]. In this chapter, it is
particularly relevant to disclose the fact that dementia patients can be proven to be
inappropriate for euthanization treatment, both on the basis of their majority high-
level of anti-somnogenic cytokine levels and on the basis of brain survival mecha-
nisms that are successful enough to preserve the brain in the oldest dementia-
symptomatic victims.
Generally speaking, anesthetics bind to gamma-aminobutyric acid (GABA) A
subtype receptors of the central nervous system, the post-synaptic NMDA receptors
of hippocampal pathways for memory, and the two-pore-domain K+ channels of
the central nervous system, depressing signal transmission associated with con-
scious awareness for a surgical period. Extreme intravenous euthanatic administra-
tion does not reach the brain, according to manufacturer related research and
instead produces risk of organ-wide tissue damage plius gangrene [30]. This is
because the higher dosages trigger instant release of the pro-inflammatory cyto-
kines tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), and interleukin-6 (IL-
6) which are powerful repair and survival brain protective cytokines [39, 40].
These cytokines modulate centers of wakefulness regulation located in the
hypothalamus, the basal forebrain and the brain stem by influencing substances
involved in sleep–wake-behavior such as adenosine, nitric oxide (NO), nuclear
factor-κB (NF-κB), prostaglandin D2 (PGD2), the neurotransmitters γ-
aminobutyric acid (GABA), glutamate and norepinephrine, as well as hormones
such as growth hormone-releasing hormone (GHRH) and corticotropin-releasing
hormone (CRH). However, several key cytokines including IL-4, IL-13 and TGF-β
are anti-somnogenic (wakefulness triggering) [41]. If so, queries against forced
euthanization of Alzheimer’s disease should include high-risk of patient awakening
susceptibility during the process, resulting in opportunity for greater error and
patient suffering (see Figure 1 below).
At the time of researching, Dutch physicians reportedly still seem to choose to
administer pentobarbital at 9 g/L as the primary euthanatic, which is well above the
0.5 mg/L safe maximum (see online pharmaceutical manufacturing warnings
[42, 43]. 71% of patients, dementia and non-dementia, are euthanised at home [30].
Methods of testing brain death and pain detection still include the Bispectral Index
monitor (BIS), NeuroSense monitor and Analgesia Nociception Index monitor.
There are evidence of pain and suffering, awakening, and discomfort during the
euthanization, despite that it is promoted as a dignified pain-free method of termi-
nation from irreversible disease conditions [44].
And yet, the law refers to the patient’s advance request to receive euthanization
on behalf of preserving self-dignity which is separated from medical
decisionmaking in itself. If so, there is an unchecked expression that could be
interpreted as a mandate to destroy dementia-patients who visibly fail to prevent
their symptoms from violating rules of local social dignity. If so, then this contra-
dicts the claim of compassionate reasons for euthanization in the law-making.
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In this chapter, a description is given of both. It includes:
I.Measurement of decisionmaking decline in brain-disease related dementia;
and,
II.Measurement of conscious-state transition impairment, and capacity to
accommodate euthanatic administration.
2. Measurement of decision-making decline in brain-disease related
dementia
Decision-making decline in dementia patients [45] can be measured by using
tests for autonomic non-conscious learning and recall expression [46]. The rates of
learning and recall are measured from responses to an unconditioned stimulus (US)
that is associated with a subsequent aversive conditioned stimulus (CS) [47]. Tests
are described abundantly throughout the literature as the basis of cognitive
decisionmaking [48–50] evaluation. The results are matched with the arrival of short-
term neurosynaptic plasticity changes in corresponding neocortical amygdaloid-
hippocampal-prefrontal cortical networks [51], as demonstrated by fMRI images
offered in the Human Connectome Project (HCP) database [52, 53], relative to the
disease etiology. XR-investigations are appropriate before stages of profound delir-
ium in advanced dementia [54]. Delirium is defined by the Diagnostic and Statisti-
cal Manual of Mental Disorders, 5th edition (DSM-5) to include acute disturbance in
attention, awareness, and cognition. The European Delirium Association and
American Delirium Society (2014) describe its increased mortality rate [55]. Delir-
ious patients suffer from severe disturbances of the circadian system [56]. And so,
XR sessions as described in this chapter offer a diurnal monitoring method to
predict the arrival of impaired day-night rhythm in patient dementia-related dis-
ease progression, long before stages of delirium have arrived.
Portable virtual reality devices that can simulate 360-degrees of 3D- immersive
environments in videogame processing have been used in cognitive decision-
making diagnostics and therapeutics. They can be scripted with internally-animated
virtual cameras and objects, known as assets to trigger patient sensorimotor interac-
tion and focus. The engagement parlays into recognition behaviors which can be
recorded as data with simultaneous autonomic cardiologic variation measurements
as frequently as needed in devices that stream the videogame up to 60 or more
frames a second. Also known as serious games or medical virtual reality behavioral
tests [54, 57], these videogames require a minimum set of calibration so that the
collection of data from the patient (also referred to as the player) is medical-
meaningful in investigations of decision-making decline and more.
For example, these include psychiatric considerations for:
1.Duration of each session which is minimized to avoid optogenetic influence
on the patient bioreceptive retinal cells;
2.Diurnal (circadian) times of day that can report challenges due to brain
inflammation transition stages, i.e. from inflammatory repair periods during
the night to inflammatory protection during the day;
3.Patient locomotor stabilization and non-navigational requirements against
disorientation and injury;
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4.Bioperceptive capacity versus retinal limitations that reduce visual motion-
detection and circadian synchronization;
5.Headturning rates, restrictions and sensorimotor ease;
6.Heart-rate variation monitoring that is reliable throughout each XR-test
session;
7.Saccadic “blink” synchronization with behavioral sampling;
8.Real-world time of day consistency of the XR-session for both scotopic and
photopic illumination intensity calibrations;
9.Statistical evenness in game scenes without the use of biased cultural asset-
objects in the environment;
10.Geotimestamped coordinates of player position and any testing-related assets
and events;
11.Alignment of player data with existing patient psyhiatric evaluations and
clinical epidemiological research; plus,
12.Appropriate asset-labeling, tagging, data-reporting standards and patient
privacy integrations.
The reader is encouraged to review a detailed description of how these features
may be presented in a Supplementary Materials section titled, Example XR-setup for
Decision-making Decline Monitoring of Dementia Patients.
3. Measurement of conscious-state transition capacity under euthanatic
administration
The thalamocortical pathway is central to cortical network information
processing during conscious-state transition behavior [58] including auditory and
visual sensory information response with emotion-based learning and recall net-
works. It is influenced by bioperception related retinal vibrations received via the
suprachiasmatic nucleus and retinohyptothalamic tract, along with influence from
genetic signaling (e.g., CLOCK, BMAL1 and others) governing overall homeostasis
[59–61]. The networks include the primary and secondary association area networks
of the brain neocortex, as well as networks involving the orbitomedial prefrontal
cortex (OMPC, areas 11 & 12) as part of the region described by the limbic cortex
and septal nuclei (including the amygdala) on behalf of patient mood regulation
monitoring, the hippocampus, the thalamus and basal ganglia which are directly
involved in sleep/wake environmental awareness-states [62]. The disruption of
these networks occurs from circadian desynchronization and the persistence of
neuroinflammation [63]. Images of such disruption and the resulting network
changes from neurodegeneration can be seen in detail from fMRI image
repositories provided by the Human Connectome Project [52], the Alzheimer’s
Disease Connectome [64], and similar collections. In fact, a future generation
Connectome project might include the complementary circadian-calibrated
XR-based data collected from dementia patients across multiple demographics,
for key times of day, pre-dawn, mid-day and pre-dusk to dusk. A schematic for a
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potential model of selected networks with the Human Connectome is shown
in Figure 2, below.
Currently, no tool exists to measure consciousness or self-consciousness objec-
tively by any machine [65]. In non-communicative patients, its estimation requires
the interpretation of motor responsiveness [66]. This response represents active
brain processing events in the Primary Motor Cortex (MI, area 4) in the precentral
gyrus and the corticospinal tract which has its own relationship to somatotopic
organization for specific movement coordination, in general with other sensory
processing information via a major thalamic motor nucleus, including its ventral
Figure 2.
Schematic example of a selected nucleic-network XR model using the human connectome project (HCP). HCP
hosts detailed neuromorphological fMRI datasets combining networks from dementia and related human and
animal pathology treatment records. An assembly of virtual reality (XR) monitoring programmes can be
organized to support integration with HCP data collections for dementia patients, focusing on any range of
selected neuronal-nucleic networks.
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lateral nucleus (VL) and Ventral anterior nucleus (VA), and in the presence of
dementia-related inflammation [67, 68].
In the Supplementary Materials, a list of some of the parameters are explained so
that optogenetic waveform signals are consistent within the virtual reality scene as
they are in the natural environment that activates synaptic relays between the
intralaminar nucleus of the thalamus and the sensory-information processing corti-
cal networks. These are the same brain regions associated with awareness of self, in
relationship to the environment.
Testing in XR can be used to evaluate the degree of this circadian desynchro-
nization in dementia patients, as long as phototopic and scotopic illumination set-
tings are maintained for real-world time-of-day concurrently. γ-Amino-Butyric-
Acid (GABA) is necessary for refinement of the circadian firing rhythm that main-
tains healthy conscious-state transition processes throughout every brain region via
the suprachiasmatic nucleus [69] and connecting intergeniculate leaflet (IGL) and
retinohypothalamic tract to thalamocortical and related nuclei (Figure 3) is
responsible for healthy circadian integration of environmental-information
throughout multiple cellular oscillations [13] in observable brainwaves.
Circadian daylight regulation [70] via the suprachiasmatic nucleus is also crucial
to the production of anti-inflammatory melatonin and so, it would be questionable
to find XR-circadian related prosthetics lacking in palliative care for dementia
patients.
Melatonin, secreted by the pineal gland, protects neuronal cells with its antiox-
idant and anti-amyloid properties, and helps to limit or reduce formation of amy-
loid fibrils involved in Alzheimer-like tau hyperphosphorylation [71, 72]. In
neuroinflammatory dementia patients, phase shifts of daylight into dusk trigger
agitation, aggression, and delirium during the late afternoon and early evening
hours [73], a behavioral regulatory challenge known as sundowning [74]. Medically,
it is vital to incorporate this condition as a risk of additional suffering during
euthanization administration, particularly where euthanatic neurotoxic delivery
does not reach the brain and the patient is already conscious-state transition
severely impaired (see Figure 4).
The XR-tests in conscious-state transition offer an opportunity to evaluate
retinal-support as part of psychiatric comfort targets [75] or, to evaluate potential
pharmaceutical risk of overdosing a dementia patients.
Figure 3.
A simplistic schematic of the bioperception circadian excitatory (yellow) and inhibitory (green) response
neuronal-nucleic network relationships, for XR-calibration development purposes.
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4. Summary
In this chapter, an XR-based method for evaluating decision-making compe-
tence is presented. in reaction to a recent dutch law that suggests decisionmaking
incompetence is sufficient grounds for non-voluntary euthanization of dementia
patients. Instead, this chapter proposes that decision-making needs to be measured
precisely along with conscious-state transition using XR. This is because majority of
dementia patients cannot transition from alert or rest state to death state instantly,
and that this predisposes them to high risk of brain aware and awake state, includ-
ing for the duration of the euthanatic product half-life, and despite cardiac arrest.
And so, the dutch law which currently only describes patient-disease irreversibility
and social dignity loss, appears to overlook the need to evaluate disease conditions
and patient conditions for which euthanization is not medically safe and non-
voluntary euthanization of such patients is cruelty.
XR-based tests are described as short-instance virtual environmentally-
interactive tests, provided in diurnal sessions that have been calibrated to the
circadian optogenetic settings of neuronal-nucleic brain thalamocortical networks.
The tests provide opportunity to demonstrate neuroinflammation progression and
the impact of high expression of anti-somnogenic cytokines, the loss of anti-
inflammatory neuroprotective melatonin and circadian desynchronization to the
patient. This makes XR-based monitoring in palliative patient caregiving generally
valuable as well as key to evaluation of euthanization-readiness.
Figure 4.
Relationship of melatonin absence and elevated risk of dementia alert/awake or risk of convulsion.
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A. Appendix
A.1 Example XR-setup for decision-making decline monitoring of dementia
patients
A.1.1 XR-scene development technology
Any state-of-the-art software can be used for dementia-related testing, such as
Unity3D ®, Unreal ®, which are designed for maximum accessibility and ease-of-
development for diverse developers. They lack psychiatric calibration and features
suited to patient cognitive behavioral environmental-interactive capture and
heartrate AI, as well as geographic solar-shadow and weather calibration for both
illumination intensity draws and audio. Last but certainly not least, the player
analytics do not accommodate sampling frequencies and these will need to be hand-
built, which leads to significant reduction in frame rates at the time of this chapter’s
writing. For this reason data needs to be stored on the device for post-session upload
and integration into an appropriate repository. In general, leading palliative care
institutions should try to achieve approximately 600 longitudinal sessions per
patient for at least 1200 patients56 to generate a suitable diagnostic game AI algo-
rithm [57]. These totals represent average numbers of records submitted to the
previously-mentioned Human Connectome Project, for example.
Ethical consideration: Large commercial database hosting sellers are eager to
acquire patient data for free. And yet, healthcare costs of the producer, the demen-
tia patient, and the time and technology costs are abandoned or ignored. A fee per
interaction should be required from the sellers per frame, and reimbursed towards
the patient’s full needs, particularly those patients and teams who seek rehabilita-
tion strategies and research for immediate potential curative-care opportunities
with XR-related prosthetics.
The simplest platform or device that is VR-enabled and lightweight for hosting a
real-time XR-scene for a stationary player is suitable. This can include a basic phone
such as a Samsung(R) 10 or 10+ in a Gear VR headset, or an Oculus Rift product,
and similar. The ideal software will include AI-calibrated illumination intensity and
unbiased wavelength delivery, from a light-emitting diode (such as an AMOLED
strip) plus brightness settings that can be adjusted manually by the team. It will also
collect geographic coordinates of the player, plus time-of-day and ambient light,
pollution and player Fowler’s position, heartrate plus saccadic blinking and eye-
tracking. The data collected may need to be temporarily stored on the device and so
it should also have sufficient hardware capacity both to allow non-occluding GPU
rendering and device storage for a 3-minute game processing and behavioral sam-
pling every 30 seconds, minimum at a framerate no less than 32 to 45 frames per
second. In a headset, ensure that audio settings conform to any hearing aid or other
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prescription settings. The same is true for visual aid adjustments in the VR-headset.
Handheld peripherals should not be used or required for dementia autonomic
cognitive decision-making and conscious-state transition settings. The patient
should not be required to navigate at any time and a member of the diagnostic
patient caregiving team is responsible for the condition, use and removal of the
XR-assembly from the patient in all sessions.
A.1.2 Significant parameters
Waveform calibration parameters describe phototopic and scotopic settings.
A.1.3 Scene environments
Testing environments for adult-onset dementia-related patients should not be
designed to evaluate decisions based on visible timer scoring, navigation decisions
through civil-type architecture or semantic response requirements. These do not
represent measure states of neuroinflammation-affected decision-making, based on
short-term learning and recall.
Sky and ground assets above the horizon should be reported in the asset-
inventory as either left and right orientable.
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Parameters that describe the maximum spread of the wavelength field such as
fulcrum depth and width can also be used to evaluate conscious-state transition
where there are compounding or ageing related deficits in one or both hemispheres.
These parameters describe the geometric projection of the user’s virtual camera-space
and orientation of the player’s head rotation and line of direction in the virtual scene.
The raycast direction is the parameter used in scripts of assets to report the
player’s line of direction. The raycast direction describes direction of focus , and is
key to describing a change in patient conscious-state. The rate of change of raycast
direction is used in behavioral response measurements in recognition and recall of
an asset during a nonconscious test.
A.1.4 Light wavelength calibration
Wavelength intensity can be given for assets in parameters from all assets,
including sky and ground, vegetation, weather and wildlife. The parameters can be
described as0-1 transparency alpha, depth projection, non-spectral shading compo-
nent size, reflective source component size, rate of single-asset motion (blur), land-
scape contrast intensity (sharpness), and scene illumination intensity, whichever is
appropriate and convenient to describing striking behavioral response differences.
The most critical wavelengths are blue:450–485 nm 620–680 THz 2.64–2.75 eV
and red: 625–740 nm 405–480 THz 1.65–2.00 eV on behalf of impact to hippocam-
pal neuronal, and genetic signaling targets involved in transcription/translation
feedback loop of CLOCK and BMAL1, and the nucleus basalis magnocellularis pro-
jections to the suprachiasmatic nucleus (SCN) mentioned in the main chapter text
and shown in Figure 3. Cone and melanopsin signaling determines brightness
perception. There are references available which suggest that melanopsin excitation
takes place at brightness equal to 1 cd  m2 for an equal-energy-spectrum light at 1
cd  m2. The maximum range should lie within 380- 780 nm, which represents the
range of skylight visible to human bioperception from pre-dawn to post-dusk.
A.1.5 Retinal luminance
Luminance is in the research to have a defined photon catch of around 480 nm
of opsin.
For this reason, maximum error in the device rendering of luminance should be
no more than 10% from this value based on maintaining exactly 480 nm spectrally
per session.
Mobile device platform manufacturers have responded to health-risk concerns
in reported from excess levels of LED blue-light exposure [76]. On the other hand,
the research suggests improvements to these same conditions [77, 78]. For these
reasons, timing and duration of a virtual reality monitoring session should be
coordinated to start at the first eye-blink, and no longer than three (3) minutes. In
fact, the first sampling of sensori-motor response and heart rate should be at the
instance of the first patient saccadic (blink). This ensures coordination of the data
collection with the timing of innate cognitive recognition such as orientation or
focus and dorsomedial prefrontal cortex response signaling. It includes the arrival of
a new spatial learning event in the hippocampal brain region.
A.1.6 Event rendering
For sky this can also include stimulatory parameters that increase the decision-
making integrity challenge, including parameters such as: sky-to-grand relative
volume and types of event, such as fog-cloud-rain particle settings. Similarly,
parameters for ground can include: ground illumination intensity, ground volume
12
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and vegetation-variation, vegetation-windspeed events and so on. Keep in mind
that virtual reality involving scores and changing scenes can trigger psychological
discomfort, dizziness, eye-strain and even addiction [79–81]. For this reason, there
should be only one scene with nature-related motion such as wind in grass or tree
branch swaying, and water ripples rather than ground buoyancy.
A.1.7 3D-Audio
Audio settings are vital to immersive realism but, may be varied on left and
right, such as for early dementia-related auditory-thalamocortical peri-operative
risk evaluation or for patient prescription purposes. Manufacturer settings usually
offer sufficient audio control parameters.
A.1.8 Scene bias
No civil society structures, roads, signs whether semantic or drawings, volume-
measurement, clock-measurement or human relationship and non-nature type cue
references should be included in neurobehavioral XR-testing that is intended to
predict the condition of neuronal-nucleic cellular health or tissue functioning.
A.1.9 Behavioral sampling
Thirty second sampling intervals to collect the sensorimotor response and
heartrate variation represents successive periods for potential long-term synaptic
potentiation in the patient, such as would belong to a learning or decision event
based and with matching cerebroarterial blood flow occurring in potential simulta-
neous XR-fMRI BOLD patient observation. Since daylight variations is composed of
wavelengths of light whose frequency and phase change with the position of the
sun, it is important to sample for all significant periods of the day in which daylight
variation is significant, i.e. the behavioral response from pre-dawn all the way to
post-dusk in 3 minute intervals for minimum of 5 or 6 XR-testing sessions, as shown
in the sampling tables, below. During an XR-session, wavelight phase information
stimulates the retinal cells depending on the device illumination levels (sometimes
referred to as Troland units, representing retinal illumination from 1mm2 pupil area
exposed to 1cd/m2 (candelas/m2) of scene light). Light information is translated
vibromechanically by the photosensitive retinal ganglion cells onto the
suprachiasmatic nuclei cells which directly stimulate the hippocampal neural bed
for short-term neuronal growth. The process relies on intracellular transport via
light-sensitive heterodimerization which recruits specific proteins in hippocampal
neurons, involving recycling endosomes on behalf of neuron axon outgrowth [82].
If XR is used as a circadian prosthetic, this information can be helpful to measuring
the amount or volume of full daylight needed for restoring circadian synchroniza-
tion, using known optogenetic principles of cellular mitochondrial activation and
targets in the retinohypothalamic and limbic region circuitry [83].
During a single test event an unconditional stimuli (US) is followed by an
unknown conditional stimulus (CS) to the patient, as described in the chapter. This
can be for example, a sudden thunder event in a random location that follows the
appearance of a bird. The response to the stimuli should be reasonable but signifi-
cant enough to trigger a cognitive autonomic learning process in healthy controls so
that the response behavior is repeated at the next appearance of the same bird, even
if the thunder does not occur. In this process, nonconscious autonomic
decisionmaking behaviour can be recorded by any XR-scripts that report the raycast
change of direction associated with the patient’s change of focus and change of
heartrate. In Alzheimer’s Disease related dementia, for example, there would a
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noticeable delay in heartrate variation at the time of change of raycast direction. In
mid-day testing, learning and recall decisionmaking might appear to be signifi-
cantly greater than in dusk-based sessions for a wide variety of dementia related
diseases. This is because the pathway between the photosensitive retinoganglion
cells to the thalamocortical nuclei may be compromised by the disease, such that the
hippocampal cells via the retinohypothalamic tract do not receive sufficient day-
light phase management information. The loss of daylight wavelength variation
from pre-dawn to post-dusk impairs conscious-state transition and increases patient
confusion and risk of sleep disruption and hallucination.
A.2 Examples of XR-data-collection setup
Session: Control Mid-day (photopic scene):
Patient device optimization check
Heart rate streaming check.
This requires checking the asset acoustic and animation visibility for distant, near, left and right positions, plus in sky and on ground)
Note: Patient is standing or seated and stationary at all times.
Distant: <20,000m virtual radius




















0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Sky Contrast
ratio-right
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Contrast Sky-
Ground









Session: Pre-dawn (photopic scene):
Nonconscious asset is animated on the ground level, in a distant, near, left or right start position
Note: Patient is standing or seated and stationary at all times.
Note: Patient is standing or seated and stationary at all times.
Distant: <20,000m virtual radius









US left CS left US left End
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0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Sky Contrast
ratio-right
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Contrast Sky-to-
Ground









Example Pre- to Post-Dawn Interval: 20-50 minute
Session: Post-dawn (photopic scene)
Ground-level asset-test
Nonconscious asset is animated on the ground level, in a distant, near, left or right start position.
Note: Patient is standing or seated and stationary at all times.
Distant: <20,000m virtual radius









US left CS right US left End










0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Sky Contrast
ratio-right
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Contrast Sky-to-
Ground
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Example Post-Dawn to Mid-day Interval: 4 hours
Session: Mid-day (no shadow) (photopic scene)
Nonconscious asset is animated on the sky level, in a distant, near, left or right start position
Note: Patient is standing or seated and stationary at all times.
Distant: <20,000m virtual radius
Near: <1000m virtual radius
Luminance (log cd/m2): 4 to 6
Pupil diameter (mm): 6 to 8
Retinal illuminance (log Trolands): Photopic > 4.5 /Scotopic 0
Active photoreceptors: cones









US left CS left
or right
US left End










0.5 0.5 0.5 0.8 0.8 0.5 0.5 0.5 0.8 0.5 0.5
Sky Contrast
ratio-right
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Contrast Sky-to-
Ground









Example Mid-day to Pre-dusk Interval: 6 - 8 hours
Session: Pre-dusk (photopic scene)
Nonconscious asset is animated on the sky or ground level, in a near left or right start position
Note: Patient is standing or seated and stationary at all times.










US left CS left US left End
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Sky Contrast
ratio-left
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Sky Contrast
ratio-right
0.5 0.5 0.5 0.8 0.5 0.5 0.5 0.5 0.8 0.5 0.5
Contrast Sky-
Ground









Example Pre-Dusk to Post-Dusk Interval: 20-50 minutes
Session: Post-dusk (photopic scene)
Nonconscious asset is animated on the ground level, in a near left or right start position
Note: Patient is standing or seated and stationary at all times.
























0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Sky Contrast
ratio-right
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Contrast Sky-to-
Ground









Session: Post-dusk (photopic scene)
Nonconscious asset is animated on the ground level in a near, left or right start position
Note: Patient is standing or seated and stationary at all times.














Sampling times 00:00:00 00:00:30 00:00:60 00:01:05 00:01:10 00:01:30 00:02:00 00:02:30 00:02:32 02:34 03:00
Heart rate
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0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Sky Contrast
ratio-right
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Contrast Sky-to-
Ground









Session: Post-dusk (starry-night scatter) (photopic scene)
Nonconscious asset is auditory in the sky or ground level, in a distant, near, left or right start position
Note: Patient is standing or seated and stationary at all times.
Distant: <20,000m virtual radius
Near: <1000m virtual radius
Luminance (log cd/m2): -6 to -4
Pupil diameter (mm): 7.1 to 6.6
Retinal illuminance (log Trolands): Photopic < -0.62 /Scotopic -4.0 to 0.70
Active photoreceptors: rods























0 0 0 0 0 0 0 0 0 0 0
Sky Contrast
ratio-right
0 0 0 0 0 0 0 0 0 0 0
Contrast Sky-to-
Ground









Repeat the above, for Scotopic settings and report.
Compare and analyse daily mid-day decision-variation longitudinal data.
Refer to rate of loss of conscious-state transition as:
Behavioral range > 0
18
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Heartrate variation (time of US event recognition) = Heartrate variation (recall
of CS event)
And
Headturn rate or focus > 0 and raycast-direction collides with the CS event
location of asset
function Update () {
var hit : RaycastHit;








change to a US-trigger (based on change of raycast direction and speed) relative
to patient heartrate variation, for dusk versus mid-day and dawn versus mid-day
behavioral responses.
In general, this could verily indicate a medically-prohibitive gradient for
euthanatic administration.
A.3 Additional evidence-seeking requirements recommended prior to
non-voluntary patient killing including physician account investigation
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